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        INTRODUCTION  
  Myosin binding protein C (MyBP-C) is a sarcomeric 
protein comprised of repeating domains that are ho-
mologous to either Ig or fi  bronectin type III domains 
(  Einheber and Fischman, 1990  ;   Furst et al., 1992  ;   Gautel 
et al., 1995  ). Skeletal isoforms of MyBP-C contain 10 
such domains, termed C1 through C10, whereas cardiac 
MyBP-C (cMyBP-C) contains an additional Ig domain at 
its N terminus, referred to as C0 (see   Fig. 1  ). Between 
domains C1 and C2 is a linker sequence, termed the 
MyBP-C   “  motif,  ”   that is highly conserved among the dif-
ferent MyBP-C isoforms (  Gautel et al., 1995  ). 
  Sequence analysis of the motif shows that it is unique 
to MyBP-C proteins, but its functional signifi  cance is 
not well understood. A regulatory role for the region has 
been proposed based on observations that the cMyBP-C 
motif is phosphorylated by protein kinase A in response 
to inotropic stimuli (  Gautel et al., 1995  ;   Gruen et al., 
1999  ). The motif also binds myosin S2 ( Gruen and Gautel, 
1999  ), and phosphorylation by protein kinase A abol-
ishes binding, suggesting that the motif  –  S2 interaction 
is important for the regulatory effects of cMyBP-C. Con-
sistent with this idea, recombinant proteins containing 
the motif increased Ca 
2+   sensitivity of tension in perme-
abilized cardiac myocytes and skeletal muscle fi  bers 
(  Kunst et al., 2000  ;   Harris et al., 2004  ) and biphasi-
cally activated and inhibited actomyosin interactions 
in in vitro motility assays (  Razumova et al., 2006  ;   Shaffer 
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et al., 2007  ). However, in motility assays the functional 
effects of either full-length cMyBP-C (  Saber et al., 2008  ) 
or its N-terminal domains (  Shaffer et al., 2007  ) did not 
depend on binding myosin S2, suggesting that interac-
tions of the motif with ligands other than S2 are impor-
tant in mediating the functional effects of cMyBP-C. 
Alternatively, sequences outside the motif could medi-
ate observed functional effects of the cMyBP-C N termi-
nus. Consistent with the latter idea, the cardiac-specifi  c 
C0 domain has been reported to bind actin and in-
crease Ca 
2+   sensitivity of tension (  Kulikovskaya et al., 
2003  ).   Herron et al. (2006)   also found that a proline-
alanine  –  rich region preceding C1 activated contraction 
independent of Ca 
2+   in permeabilized cardiac prepara-
tions. The MyBP-C motif was not required for the latter 
activating effects. However, effects were only observed 
at high protein concentrations, and it was not deter-
mined whether activating effects persisted in the pres-
ence of Ca 
2+  . 
  The purpose of the current study was to assess the 
importance of the MyBP-C motif in affecting actomyo-
sin contractile properties, either alone or in combina-
tion with other N-terminal domains of MyBP-C. Results 
demonstrate that the MyBP-C motif together with the 
C1 domain is necessary for effects of the N terminus 
of cMyBP-C to increase Ca 
2+   sensitivity of tension, in-
crease rates of tension redevelopment (  k    tr  ) at submaxi-
mal [Ca 
2+  ], and increase tension development in the 
absence of Ca 
2+  . 
  Contribution of the Myosin Binding Protein C Motif to Functional 
Effects in Permeabilized Rat Trabeculae 
    Maria V.     Razumova  ,   Kristina L.     Bezold  ,   An-Yue     Tu ,   Michael     Regnier  , and   Samantha P.     Harris   
  Department of Bioengineering, University of Washington, Seattle, WA 98195 
          Myosin binding protein C (MyBP-C) is a thick-fi  lament protein that limits cross-bridge cycling rates and reduces 
myocyte power output. To investigate mechanisms by which MyBP-C affects contraction, we assessed effects of re-
combinant N-terminal domains of cardiac MyBP-C (cMyBP-C) on contractile properties of permeabilized rat car-
diac trabeculae. Here, we show that N-terminal fragments of cMyBP-C that contained the fi  rst three immunoglobulin 
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main  ”   increased Ca 
2+   sensitivity of tension and increased rates of tension redevelopment (i.e.,   k  tr    ) at submaximal 
levels of Ca 
2+  . At concentrations   ≥  20   μ  M, recombinant proteins also activated force in the absence of Ca 
2+   and in-
hibited maximum Ca 
2+  -activated force. Recombinant proteins that lacked the combination of C1 and the motif did 
not affect contractile properties. These results suggest that the C1 domain plus the motif constitute a functional 
unit of MyBP-C that can activate the thin fi  lament. 
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up to 1 wk in glycerinated relaxing solution at 4  °  C. All skinning 
and storage solutions contained protease inhibitor cocktail (P8340; 
Sigma-Aldrich). 
  Experimental Apparatus 
  The apparatus for force measurements is shown schematically in 
  Fig. 2  .   Permeabilized trabeculae were transferred from a glass 
Petri dish to a temperature-controlled stainless steel plate contain-
ing six experimental chambers (Aurora Scientifi  c Inc.). The fi  rst 
chamber contained relaxing solution and was large enough to 
facilitate mounting of a trabecula between a force transducer 
(model 400A; Aurora Scientifi  c Inc.) and a torque motor (model 
312C; Aurora Scientifi  c Inc.) for rapid adjustments of fi  ber length. 
Trabeculae were secured to the force transducer and motor as 
shown in   Fig. 2   by placing each end of a trabecula into a trough 
constructed from a bisected 25-gauge needle. The ends of the tra-
becula were then overlayed with a segment (    1 mm in length) of 
4.0 suture material. The suture and trabecula were next secured 
to the trough by tying with a strand of unwaxed dental fl  oss (ap-
proximately equivalent to 10.0 suture thread). After securing each 
end of the trabecula, the entire stainless steel plate containing the 
experimental wells and the trabecula was placed on the stage of 
an inverted microscope (IX71; Olympus) fi  tted with a 12  –  mega 
pixel digital camera (DP70; Olympus) for visualization of the tra-
becula and measurement of fi   ber dimensions and sarcomere 
length. Sarcomere length was adjusted to     2.3   μ  m in relaxing so-
lution and monitored throughout the course of an experiment. 
  Experimental Protocols 
  pCa Solutions.     Relaxing and activating solutions were prepared 
using a custom software package as described previously (  Martyn 
et al., 1994  ;   Regnier et al., 2002  ). Solutions were maintained at 
0.18 M ionic strength and pH 7.0 at 15  °  C and contained (in mM): 
15 phosphocreatine, 15 EGTA, 80 MOPS, 1 free Mg 
2+  , at least 38 
Na 
+   plus K 
+  , 1 dithiothreitol, and 5 ATP. Ca 
2+   concentration (re-
ported as pCa =     log[Ca 
2+  ]) was set by varying amounts of CaCl  2  . 
  Steady-state Force 
  The amount of force generated in a given experimental solution 
was measured as the difference in calibrated output voltage of the 
force transducer recorded before and after rapid slackening of a 
trabecula to 80% of its resting length (where resting length was 
set at sarcomere length of     2.3   μ  m). Input commands to the 
  MATERIALS AND METHODS  
  Expression and Puriﬁ  cation of Recombinant MyBP-C 
N-terminal Proteins 
  N-terminal cMyBP-C proteins containing the C0C1, C1C2, or 
C3C4 domains were cloned with and without the MyBP-C motif 
(  Fig. 1  ) by PCR amplifi  cation of desired sequences from the full-
length mouse cMyBP-C cDNA sequence (GenBank accession 
no.   AF097333  ).   C1C2(-m) lacked 82 amino acids of the motif 
sequence beginning at residues LRSAFRR and ending at DL-
RGMLK, whereas C3mC4 included 100 amino acids of the motif 
beginning at DLDLRSA and ending at DEKKSTAF. Motif se-
quences of C0C1m, C1m, and mC2 included 5 additional amino 
acids and ended at AFQKKLE. Recombinant constructs were sub-
cloned into the pQE-2 expression vector (QIAGEN) in frame 
with a 6X His-tag at the N-terminus of the clone sequence to facil-
itate protein purifi  cation. Protein expression in M15 cells (QIA-
GEN) was induced by IPTG, and expressed proteins were purifi  ed 
under native conditions using a Ni-NTA affi  nity column accord-
ing to the manufacturer  ’  s directions. After column elution, frac-
tions containing the expressed protein were pooled and dialyzed 
into AB buffer (in mmoles/L): 25 KCl, 25 imidazole, 4 MgCl  2  , 
1 EGTA, and 1 DTT. Protein concentration in AB buffer was de-
termined by protein assay (Thermo Fisher Scientifi  c) using bo-
vine gamma globulin as a standard or by UV absorbance at 280 nm 
using theoretical extinction coeffi  cients calculated from protein 
primary sequences. 
  Preparation of Permeabilized Cardiac Trabeculae 
  Treatment of all animals was in strict accordance with the guide-
lines and protocols established by the Institutional Animal Care 
and Use Committees at the University of Washington and the 
University of California, Davis. Male Sprague-Dawley rats (200  –
  250 g) were killed by intraperitoneal injection of sodium pen-
tabarbitol. Hearts were then rapidly excised, and right ventricles 
were dissected in a Ringer  ’  s solution containing (in mM): 100 
NaCl, 24 NaHCO  3  , 2.5 KCl, 1 MgSO  4  *7H  2  O, 1 Na  2  HPO  4  , and 
1 CaCl  2  . Trabeculae were permeabilized in situ by incubation of 
splayed ventricles overnight in a relaxing solution (in mM: 100 
KCl, 10 imidazole, 2 EGTA, 5 MgCl  2 , and 4 ATP) containing 50% 
glycerol and 0.4% Triton X-100 (Sigma-Aldrich) at 4  °  C. Individ-
ual trabeculae were then dissected from ventricle free walls, 
pinned to the bottom of a sylgar-coated Petri dish, and stored for 
  Figure 1.     Schematic diagram showing the 
domain organization of cMyBP-C. (Top) 
Full-length cMyBP-C. (Bottom) Recombi-
nant proteins used in this study.         Razumova et al.  577 
ing Ca 
2+   (i.e., at pCa 4.5) at the beginning and the end of each se-
ries of submaximal force measurements. Typically, the decline in 
force from the fi  rst measurement in pCa 4.5 to the last pCa 4.5 
measurement was   <  10%. Data from experiments in which the to-
tal decline was   >  15% were discarded. This included experiments 
in which multiple force  –  pCa relationships were measured in a 
single trabecula. 
  Force-pCa data were plotted by expressing submaximal force 
(  P  ) at each pCa as a fraction of maximal force measured at pCa 
4.5 (  P    o  ), that is   P  /  P    o  , where   P  /  P    o   =   P    rel  . The pCa  50   and slope, n  H  , 
for each curve were determined by fi  tting the normalized data to 
the Hill equation: 
     P
P
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  Rate of Tension Redevelopment 
  The rate of force redevelopment (  k    tr  ) after a release and restretch 
maneuver (  Brenner and Eisenberg, 1986  ) was measured during 
each activation after steady-state force had reached a plateau value 
in a given pCa solution. Each trabecula was released by 20% of its 
motor for length control were initiated via a PC using the 600A 
software package (Aurora Scientifi  c Inc.) and delivered to the 
motor via a D/A converter. Length and force output signals were 
digitized via an A/D converter and were displayed and stored on 
a PC. All force measurements were acquired at 15  °  C. 
  The protocol to determine Ca 
2+  -activated force was as follows: 
force was fi  rst measured in a pCa 9.0 solution followed by transfer 
of the trabecula to a pre-activating solution (reduced Ca 
2+   buffer-
ing) for     2 min before transfer into an activating solution con-
taining Ca 
2+   and measurement of developed force. Ca 
2+  -activated 
force was then calculated as the difference between resting force 
measured at pCa 9.0 and the force measured in Ca 
2+  -activating so-
lutions with free Ca 
2+   concentrations of pCa   <   9.0. Final values for 
Ca 
2+  -activated force were normalized to the width of the prepara-
tion by assuming a 2:1 width/height cross-sectional area. 
  Force  –  pCa relationships were constructed from force measure-
ments as described above for a series of activations at submaximal 
[Ca 
2+  ] (pCa   >   4.5). The order of activating solutions was chosen 
randomly for each trabecula. After each Ca 
2+   activation at a sub-
maximal pCa, the trabecula was returned to relaxing solution 
(pCa 9.0). Maximal force measurements were obtained at saturat-
  Figure 2.     Schematic diagram of the appara-
tus used to obtain force measurements and 
original chart recordings. (Top, inset) Attach-
ment method for securing a permeabilized 
trabecula to metal troughs. One trough was 
attached to the active end of a force trans-
ducer and the other to a motor for rapid 
changes in length. (Bottom) Original chart 
records showing Ca 
2+  -activated force in the 
presence and absence of 5   μ  M C1C2 or 10   μ  M 
C0C1. The pCa values are shown above each 
activation, and the presence of C1C2 or C0C1 
in bath solutions is indicated by bars.     578   Functional Effects of the MyBP-C Motif 
pre-activating solutions resulted in signifi  cantly greater 
Ca 
2+  -activated force developed in submaximal pCa solu-
tions, as indicated by the leftward shift of the force  –  pCa 
relationship compared with control curves generated 
before the addition of protein.   These data thus agree with 
previous observations that C1C2 increased Ca 
2+   sensitiv-
ity of tension in permeabilized mouse myocytes (  Harris 
et al., 2004  ). However, in marked contrast to the effects 
of C1C2, 20   μ  M C1C2(-m), which lacked the motif, did 
not increase Ca 
2+   sensitivity of tension, suggesting that 
the motif is required for the effects of C1C2 on force at 
submaximal pCa concentrations. 
  To determine whether the motif was suffi  cient to in-
duce the leftward shift of the tension  –  pCa relation-
ship, we next investigated whether the motif could confer 
the ability to increase Ca 
2+   sensitivity to other segments of 
cMyBP-C. Because single Ig domains may be unstable when 
expressed alone (  Politou et al., 1994a, 1994b  ), we ex-
pressed the motif as a linker between domains C3 and C4. 
resting length for a brief (20-ms) duration followed by a rapid un-
derdamped restretch to achieve     105% of the original fi  ber length 
before returning to the original length. The slack-restretch ma-
neuver is intended to mechanically detach cross-bridges bound 
to the thin fi  lament while the thin fi  lament is activated in the pres-
ence of Ca 
2+  . The subsequent redevelopment of force after the 
slack and restretch step refl  ects the rate of cross-bridge transition 
from weakly bound to strongly bound force-generating states 
(  Brenner and Eisenberg, 1986  ). The resulting force transient is used 
to calculate   k    tr   according to the relation: 
     ktr  =  ln 0.5/t
1/2  ,    
  where t 
1/2   is the half-time of force redevelopment and   k    tr   is ex-
pressed in reciprocal seconds (s 
    1  ) as described previously (  Regnier 
et al., 1998  ). 
  Force Measurements after Incubation with Recombinant 
MyBP-C Proteins 
  Control force-pCa or   k    tr  -pCa curves were fi  rst measured for each 
trabecula as described above in the absence of added protein. 
Each trabecula thereby served as its own control. Individual tra-
beculae were then incubated for 15 min in relaxing solution (pCa 
9.0) containing added recombinant protein followed by transfer 
into a pre-activating solution that also contained added protein. 
Trabeculae were then transferred to Ca 
2+  -activating solutions that 
typically lacked added protein to avoid potentially confounding 
effects of changes in [Ca 
2+  ]. After each force measurement in a 
given Ca 
2+  -activating solution, trabeculae were rapidly returned into 
relaxing solution with added protein before the next Ca 
2+   activa-
tion. Recombinant proteins were added to the pCa 9.0 and pre-
activating solutions as concentrated stock solutions in AB buffer 
to achieve the desired fi  nal concentration. Dilution of pCa 9.0 
relaxing solution or pre-activating solutions with proteins in AB 
was typically     5% (vol/vol) but not   >  10%. Control experiments 
showed that addition of AB buffer alone (without added proteins) 
to achieve 10% dilution of pCa 9.0 or pre-activating solutions did 
not affect steady-state force or   k    tr   measurements (not depicted). 
The magnitude of force measured upon reaching steady-state in 
Ca 
2+  -activating solutions with or without added proteins was not 
different (  Fig. 2  ). 
  Statistical Analysis 
  All values are reported as average   ±   SEM. Data were compared us-
ing ANOVA followed by Bonferroni post-hoc comparisons. Signif-
icance was considered at P   <   0.05. 
  RESULTS  
  The MyBP-C Motif Is Necessary But Not Sufﬁ  cient to 
Increase Ca 
2+   Sensitivity of Tension in Permeabilized 
Trabeculae 
  We had previously shown that a recombinant protein 
containing the C1 through C2 domains of cMyBP-C (i.e., 
C1C2;   Fig. 1  ) increased Ca 
2+   sensitivity of tension in per-
meabilized mouse myocytes (  Harris et al., 2004  ). To de-
termine whether the MyBP-C motif was required for the 
effects of C1C2, we created a mutant C1C2 protein that 
lacked the motif sequence between the C1 and C2 do-
mains (i.e., C1C2[-m]) and compared its effects to those 
of C1C2 (replete with motif) on the Ca 
2+   sensitivity of 
force in permeabilized rat cardiac trabeculae. As shown 
in   Fig. 3 A  , 10   μ  M C1C2 added to relaxing (pCa 9.0) and 
  Figure 3.     Effects of the MyBP-C motif on Ca 
2+   sensitivity of ten-
sion. (A) Incubation of trabeculae with 10   μ  M C1C2 (squares; 
  n   = 6) resulted in a leftward shift of the tension  –  pCa relationship 
relative to control (circles), indicating an increase in Ca 
2+   sensitiv-
ity of tension (    pCa  50   = 0.30   ±   0.05). 20   μ  M C1C2(-m) (triangles; 
  n   = 3) that lacks the MyBP-C motif was without effect on the ten-
sion  –  pCa relationship. (B) 20   μ  M C2C4 without the motif (tri-
angles;   n   = 4) and 20   μ  M C3mC4 with the motif (squares;   n   = 3) 
had no effect on Ca 
2+   sensitivity of tension.         Razumova et al.  579 
Because the rate of tension redevelopment varies as a func-
tion of the total level of thin-fi  lament activation (i.e.,   k    tr   
is increased as a result of both Ca 
2+   and strongly bound 
cross-bridges;   Gordon et al. [2000]  ),   k    tr   values were also 
plotted as a function of the relative force obtained at 
each pCa. As shown in   Fig. 7 A  ,   k    tr   values measured after 
incubation with C0C2 were near maximal even at low 
levels of force.   Thus, C0C2 increased   k    tr   to near maximum 
levels independent of the amount of force generated or, 
presumably, the number of cycling cross-bridges. 
  As shown in   Fig. 7 B  , C0C1m and C1C2 were also ef-
fective at increasing   k    tr   at submaximal Ca 
2+  . C1m appeared 
to represent the minimal domains required for these ef-
fects. However, increases in   k    tr   induced by C1m were evi-
dent only for a limited range of pCa and force values 
below the pCa  50   of force generation (  Fig. 7 B  ). Thus, 
the order of effi  cacy for protein effects on   k    tr   was similar 
to that observed for effects on pCa  –  force relationships, 
i.e., C0C2   >   C0C1m   ≥   C1C2   >   C1m. Proteins that did 
As shown in   Fig. 3 B  , the three-domain segment C2C4 
(inclusive of C3) did not signifi  cantly affect force  –  pCa 
relationships. However, the addition of the motif between 
domains C3 and C4 (i.e., C3mC4) also failed to induce a 
leftward shift of the tension  –  pCa relationship. These re-
sults suggest that Ig domains C2, C3, and C4 do not affect 
force and that the addition of the motif to these domains 
is not suffi  cient to increase Ca 
2+   sensitivity of tension. 
  We next investigated whether the Ca 
2+  -sensitizing ef-
fects of the motif required the presence of the fl  anking 
regions C1 or C2. We therefore generated protein con-
structs that combined the motif with one or the other of 
the fl  anking domains, i.e., C1m or mC2. As shown in 
  Fig. 4 A  , the C1m construct was effective at inducing a 
leftward shift of the force  –  pCa relationship, whereas 
mC2 at a comparable concentration failed to induce a 
leftward shift.   Collectively, these results suggest that the 
motif plus C1, but not the motif plus C2, are necessary 
for the Ca 
2+  -sensitizing effects of C1C2. 
  To determine whether C1 without the motif was effec-
tive at increasing Ca 
2+   sensitivity of tension, effects of 
C0C1 were also assessed. As shown in   Fig. 4 B  , C0C1 did 
not signifi  cantly affect Ca 
2+   sensitivity of force. This 
result is consistent with observations that C1C2(-m), 
which lacks the motif but includes C1, also did not affect 
force  –  pCa relationships (  Fig. 3  ). However, the addition 
of the motif to C0C1 (i.e., C0C1m) again conferred a 
marked leftward shift to the force  –  pCa relationship. 
These results thus suggest that a combination of both the 
motif and C1 are minimal requirements for the Ca 
2+  -
sensitizing effects of C1C2. 
    Fig. 5   shows a comparison of the force  –  pCa relation-
ships for proteins containing the C1 and m-domains.  The 
relative effi  cacy of the different proteins as assessed by 
the midpoint shift in force  –  pCa relations (i.e.,     pCa  50  ) 
was C0C2   >   C0C1m   ≥   C1C2   >   C1m. Thus, although C1m 
was the minimal subunit capable of inducing a leftward 
shift of the force  –  pCa relationship, it was not as effec-
tive as proteins containing either the C0 or C2 domains 
in addition to C1m. Summary data for effects of the dif-
ferent proteins are shown in   Table I  .   
  C1 Plus the MyBP-C Motif Increase Rates of Force 
Redevelopment (  k    tr  ) at Submaximal Ca 
2+   Activation 
  To assess whether the motif or C1 affected rates of force 
activation in addition to their effects on steady-state 
force  –  pCa relationships, the rate of force redevelopment 
after a release and restretch maneuver (i.e.,   k  tr    ) was mea-
sured during each Ca 
2+   activation.   Fig. 6 A   shows repre-
sentative force recordings after a release and restretch 
protocol for control conditions in the absence of added 
protein and after incubation of a trabecula with 5   μ  M 
C0C2.   Incubation with C0C2 signifi  cantly accelerated 
  k    tr  , such that values were near maximal in all pCa solu-
tions (  Fig. 6 B  ). Thus, the Ca 
2+   dependence of   k    tr   was 
virtually eliminated by incubation in 5   μ  M C0C2. 
  Figure 4.     The combination of C1 and the MyBP-C motif is re-
quired to increase Ca 
2+   sensitivity of tension. (A) 10   μ  M mC2 (tri-
angles;   n   = 4) had no effect on tension  –  pCa relationships relative 
to control (circles), whereas 5   μ  M C1m (squares;   n   = 6) signifi  -
cantly increased Ca 
2+   sensitivity of tension (    pCa  50   = 0.12   ±   0.04). 
(B) 10   μ  M C0C1 (triangles;   n   = 3) had no effect on tension  –  pCa 
relationships relative to control (circles), whereas 5   μ  M C0C1m 
(squares;   n   = 4) signifi  cantly increased Ca 
2+   sensitivity of tension 
(    pCa  50   = 0.27   ±   0.05).     580   Functional Effects of the MyBP-C Motif 
increased force in the absence of Ca 
2+   (pCa 9.0), and 
whether maximal force in the presence of saturating Ca 
2+   
(pCa 4.5) was affected by the recombinant proteins. 
    Fig. 8   shows effects of increases in [C0C2] on Ca 
2+  -in-
dependent force developed in relaxing (pCa 9.0) solu-
tions, total force measured in pCa 4.5 solutions, and 
maximum Ca 
2+  -activated force (i.e., active force devel-
oped in a pCa 4.5 solution minus force measured at pCa 
9.0).   The data show a trend for concentrations of C0C2 
  ≥   10   μ  M to increase force independent of Ca 
2+   with acti-
vating effects in pCa 9.0 signifi  cant at 20   μ  M C0C2. To-
tal force (Ca 
2+   dependent and independent) measured 
at pCa 4.5 was reduced at 30   μ  M C0C2, and there was a 
signifi  cant decrease in the Ca 
2+  -activated component of 
force generated at saturating Ca 
2+   (pCa 4.5). Similar ef-
fects were observed for C1C2, C0C1m, and C1m (  Fig. 8  ). 
All activating and inhibitory effects were reversible after 
a 20-min washout of proteins from pCa 9.0 and pre-acti-
vating solutions.   Table II   shows summary data for effects of 
recombinant proteins on force at pCa 9.0 and at pCa 4.5.   
  DISCUSSION  
  The purpose of this study was to investigate the func-
tional signifi  cance of the unique motif or   “  m-domain  ”   
of MyBP-C in mediating contractile effects induced by 
the N terminus of MyBP-C. Results show that the motif 
is necessary but not suffi  cient by itself to induce the func-
tional effects elicited by the N terminus of MyBP-C in 
permeabilized trabeculae. Instead, results demonstrate 
that a combination of the C1 domain and the motif is 
necessary and suggest that together these domains con-
stitute a functional unit of MyBP-C. 
  The effects on contraction reported here for the C1 
domain and the motif have not been reported previ-
ously for the C1 domain or for the C1 and motif domain 
in combination with one another. However, the results 
confi  rm and extend previous observations for contractile 
effects of C1C2 (which contains C1 and the motif) and 
not contain the combination of C1 plus the motif did 
not affect   k    tr   (not depicted). 
  Effects of C1 and the MyBP-C Motif on Ca 
2+  -independent 
and Ca 
2     -activated Force 
  In all of the preceding experiments, the concentration 
of recombinant proteins used were chosen such that 
they did not signifi  cantly affect either resting force in 
the absence of Ca 
2+   (pCa 9.0) or maximum force in the 
presence of saturating Ca 
2+   (pCa 4.5). However, we fre-
quently observed that C0C2 concentrations   ≥  10   μ  M in-
creased force measured in pCa 9.0 solutions. Activation 
of Ca 
2+  -independent force by N-terminal cMyBP-C pro-
teins has been reported and was attributed to a proline-
alanine  –  rich linker sequence between C0 and C1 (  Herron 
et al., 2006  ). We therefore investigated whether pro-
teins containing this linker and/or the MyBP-C motif 
  Figure 5.     Relative effects of proteins containing C1 and the 
MyBP-C motif on Ca 
2+   sensitivity of tension. Tension  –  pCa rela-
tionships were determined after incubation of trabeculae with 
5   μ  M C1m (upward triangles;   n   = 6), 5   μ  M C1C2 (diamonds; 
  n   = 4), 5   μ  M C0C1m (squares;   n   = 4), and 5   μ  M C0C2 (downward 
triangles;   n   = 6). Data for C1m and C0C1m were redrawn from 
  Fig. 4  . Controls curves (circles) were obtained in each trabecula 
before the addition of recombinant protein.     
  TABLE I  
  Summary Data of Effects of Recombinant N-terminal Proteins on Tension  –  pCa Relationships 
Protein (  n  ) [ ] (    M) pCa  50 
   (Control)
pCa  50 
   (After protein)
    pCa  50 Hill  coeffi  cient (n  H  ) 
  (Control)
Hill coeffi  cient (n  H  ) 
  (After protein)
C0C2 (6) 5 5.32   ±   0.02 5.73   ±   0.05   
a   0.42    ±   0.04 5.43   ±   0.32 2.19   ±   0.14   
a   
C1C2 (4) 5 5.30   ±   0.02 5.54   ±   0.03   
a   0.25    ±   0.05 6.45   ±   0.86 2.65   ±   0.25   
a   
C0C1m (4) 5 5.32   ±   0.01 5.59   ±   0.05   
a   0.27    ±   0.05 7.66   ±   0.72 2.71   ±   0.34   
a   
C1m (6) 5 5.34   ±   0.02 5.46   ±   0.04   
a   0.12    ±   0.04 6.83   ±   0.89 3.72   ±   0.34   
a   
C1C2 (5) 10 5.29   ±   0.02 5.58   ±   0.05   
a   0.30    ±   0.05 5.02   ±   0.33 2.11   ±   0.14   
a   
mC2 (4) 10 5.30   ±   0.01 5.32   ±   0.03 0.02   ±   0.03 6.63   ±   0.44 5.90   ±   0.67
C0C1 (3) 10 5.34   ±   0.01 5.32   ±   0.01     0.02   ±   0.01 6.61   ±   0.70 7.50   ±   0.83
C2C4 (4) 20 5.32   ±   0.01 5.32   ±   0.01 0.00   ±   0.01 6.73   ±   0.21 6.15   ±   0.71
C1C2(-m) (3) 20 5.33   ±   0.02 5.34   ±   0.01 0.01   ±   0.01 9.62   ±   2.078 8.67   ±   2.04
C3mC4 (3) 20 5.30   ±   0.02 5.29   ±   0.02     0.01   ±   0.01 4.96   ±   0.62 5.56   ±   0.42
   
a    Signifi  cance, P   <   0.05 versus control.    Razumova et al.  581 
extended structural surface that mediates functional ef-
fects of the cMyBP-C N terminus. The idea that multiple 
Ig domains can create an extended interaction surface 
is further supported by observations that three titin do-
mains (i.e., A168-A170) constitute the binding site for 
the ubiquitin ligase, MuRF-1 ( Mrosek et al., 2007 ;  Muller 
et al., 2007  ). Alternatively, the requirement for both the 
C1 and m-domains could indicate that one domain is 
required for stabilization of the other. For instance, Ig 
domains may be unstable when expressed alone, but 
may be stabilized by additional N-terminal amino acids 
(  Politou et al., 1994a, 1994b  ). The requirement for C1 
may then refl  ect structural stabilization of the m-domain. 
In this case, effects may still be specifi  cally related either 
to C1 or the linker between C1 and the motif (  Muller 
et al., 2007  ) because C3 was unable to substitute for C1 
when the motif was placed between C3 and C4. 
  Although we did not fi  nd that other N-terminal cMyBP-C 
domains elicited independent effects on force genera-
tion, the two domains fl  anking C1m, C0 and C2, signifi  -
cantly enhanced effects of C1m (  Fig. 5  ). Of these, the 
cardiac-specifi  c C0 domain was the most effective, and 
proteins containing the combination of C0 and C1m 
(e.g., C0C2 and C0C1m) induced the greatest increases 
in Ca 
2+   sensitivity of tension. Proteins that contained C0 
along with C1m also increased   k    tr   at all submaximal acti-
vation levels and virtually eliminated the activation de-
pendence of   k    tr   (  Fig. 7  )  .   However, the effects of C0 to 
potentiate effects of C1m reported here contrast with 
another report where the C0 domain alone was suffi  -
cient to increase Ca 
2+   sensitivity of tension and inhibit 
maximal Ca 
2+  -activated force (  Kulikovskaya et al., 2003  ). 
In that study, the effects of C0 correlated with the phos-
phorylation state of endogenous cMyBP-C, such that ef-
fects of C0 were diminished when endogenous cMyBP-C 
was dephosphorylated. Because it is likely that trabeculae 
used in the current study were substantially dephosphor-
ylated (  McClellan et al., 2001  ), independent functional 
effects of C0 may not have been readily apparent. 
  The C1 and m-domains were also effective at activat-
ing force in the absence of Ca 
2+   (  Fig. 8   and   Table II  ). 
This result is similar to observations made by   Herron et al. 
(2006)   who reported that the N terminus of cMyBP-C 
activated force independent of Ca 
2+  . However, in those 
experiments the effect was attributed to a linker sequence 
rich in proline and alanine between the C0 and C1 do-
mains. In contrast, in the current experiments we found 
that the C0C1 protein that includes the pro-ala sequence 
was without effect on Ca 
2+   sensitivity of tension and did 
not activate tension under relaxing conditions at pCa 9.0, 
even at concentrations up to 50   μ  M. Although a precise 
explanation for the apparent discrepancy is unclear, spe-
cies-specifi  c differences may be relevant because mouse 
sequences were used in the current study, whereas hu-
man proteins were used in the previous work (  Herron 
et al., 2006  ). Notably, the proline-alanine  –  rich region 
localize the Ca 
2+  -sensitizing effects of C1C2 to the C1 
and m-domains. This conclusion was evident because con-
structs that lacked motif, such as C1C2(-m), C0C1, and 
C2C4, were all without effect on contractile properties 
at the concentrations tested (  Figs. 3 and 4   and   Table I  ). 
However, the motif by itself was not suffi  cient to increase 
Ca 
2+   sensitivity because neither C3mC4 nor mC2 in-
duced leftward shifts of the tension  –  pCa relationship. 
Instead, only proteins that included the combination of 
the C1 domain and the motif, such as C0C1m, C0C2 
(inclusive of C1m), and C1m, were able to increase Ca 
2+   
sensitivity of tension (  Table I  ). 
  The fi  nding that the combination of C1 and the motif 
is required to elicit contractile effects suggests that these 
two domains together constitute a functional subunit of 
cMyBP-C. Consistent with this idea, recent structural 
studies of the cMyBP-C N terminus showed that C1 and 
the motif adopt a stable spatial arrangement with re-
spect to one another, and that the arrangement is main-
tained in the presence or absence of C0 (  Jeffries et al., 
2008  ). Thus, C1 and the motif together may form an 
  Figure 6.     Effects of C0C2 on rates of tension redevelopment 
(  k    tr  ). (A) Smoothed force traces showing steady-state force mea-
surements after a release and restretch maneuver (  k    tr  ) during 
maximal Ca 
2+   activation (pCa 4.5) and during submaximal Ca 
2+   
activation (pCa 5.4). Incubation with 5   μ  M C0C2 accelerated   k    tr   at 
low Ca 
2+   (pCa 5.8) to near maximal rates. (B) 5   μ  M C0C2 acceler-
ated   k    tr   at all levels of submaximal Ca 
2+   activation.     582   Functional Effects of the MyBP-C Motif 
using human C0C1 in permeabilized skeletal muscle 
obtained results similar to those reported here and found 
that 30   μ  M C0C1 failed to affect Ca 
2+   sensitivity of ten-
sion and did not activate tension at pCa 9.0. 
differs signifi  cantly (    52% identity) between mouse and 
human and so may contribute to the functional differ-
ences observed in the two studies. Muscle type differences 
may also exist because Kunst et al. (  Kunst et al., 2000  ) 
  Figure 7.     Effects of recombinant N-terminal proteins on rates of tension redevelopment (  k    tr  ) relative to changes in force. (A) 5   μ  M 
C0C2 (triangles;   n   = 6) increased   k    tr   to near maximal at all levels of submaximal Ca 
2+   activation. (B) 5   μ  M C0C1m (triangles;   n   = 4) and 
5   μ  M C1C2 (squares;   n   = 4) increased   k    tr   to near maximal at all levels of submaximal Ca 
2+   activation, whereas 5   μ  M C1m (diamonds; 
  n   = 6) increased   k    tr   to near maximal only at values at or below the pCa  50   for force generation.     
  Figure 8.     Effects of C0C2, C1C2, C0C1m, and C1m on total Ca 
2+  -independent and -dependent force. Effects of 10, 20, and 30   μ  M pro-
tein are shown on total force at pCa 4.5 (black bars) and Ca 
2+  -independent force at pCa 9.0 (gray bars). Ca 
2+  -activated force (white bars) 
is force at pCa 4.5 minus force at pCa 9.0. Washout (Wash) shows force values after a 20-min incubation in relaxing solutions without 
added proteins.         Razumova et al.  583 
However, arguing against this scenario, S2 binding was 
not required for activating effects of C1C2 on acto-
myosin interactions in an in vitro motility assay because 
C1C2 affected motility even when S1 catalytic domains 
(without S2) were used to drive actin fi  lament sliding 
(  Shaffer et al., 2007  ). 
  Other possibilities include the idea that the different 
functional effects of C1m (e.g., to increase Ca 
2+   sensitiv-
ity of tension, increase   k    tr   at submaximal [Ca 
2+  ], and 
to activate tension independent of Ca 
2+  ) are mediated 
through separate, independent interactions with one 
or both fi  laments. In addition, the possibility that the 
observed effects of C1m are due to competition with 
endogenous cMyBP-C for binding to sites normally oc-
cupied by endogenous cMyBP-C cannot be excluded. 
This possibility seems unlikely because C1C2 also in-
creased Ca 
2+   sensitivity of tension in myocytes from 
cMyBP-C knockout mice that lack cMyBP-C (  Harris et al., 
2004  ). The latter result suggests that the observed ef-
fects are not dependent on the presence of endogenous 
cMyBP-C and therefore cannot be due to binding com-
petition with endogenous cMyBP-C. Furthermore, be-
cause cMyBP-C is present at a limited molar ratio with 
respect to myosin (  Offer et al., 1973  ;   Craig and Offer, 
1976  ), it is likely that even when endogenous cMyBP-C 
is present (as in the current experiments), a majority of 
available binding sites are open and accessible for inter-
actions with exogenously added protein. 
  The idea that exogenously added proteins can bind to 
all available binding sites and not just to those ordi  -
narily occupied by endogenous cMyBP-C might explain 
the present observations that added recombinant pro-
teins elicit a signifi  cant increase in the Ca 
2+   sensitivity of 
tension, whereas knockout of endogenous cMyBP-C had 
comparatively modest effects on Ca 
2+   sensitivity of ten-
sion (  Harris et al., 2002  ;   Stelzer et al., 2006  ). In contrast, 
knockout of cMyBP-C accelerated rates of tension rede-
velopment (  k    tr  ) at submaximal Ca 
2+   (  Korte et al., 2003  ; 
  Stelzer et al., 2006  ), similar to the effects of adding exog-
enous proteins described here. The similarity of effects 
  The fi  ndings that C1 and the motif increased Ca 
2+   
sensitivity of tension, increased   k    tr   at submaximal [Ca 
2+  ], 
and activated tension in the absence of Ca 
2+   (pCa 9.0) 
suggest that together these two domains are potent 
activators of the thin fi  lament. Although the precise 
mechanism(s) by which the C1 domain and motif exert 
these effects is not apparent from these studies, several 
explanations are possible. The fi  rst is that the C1 do-
main and the motif bind directly to the thin fi  lament 
and thereby promote its activation. According to this 
scenario, effects of C1m might be analogous to those of 
strongly bound cross-bridges. Consistent with this idea, 
the effects of C1m are similar to those of NEM-S1, a 
chemical derivative of myosin S1 that lacks enzymatic 
activity but binds strongly to and activates the thin fi  la-
ment (  Nagashima and Asakura, 1982  ;   Swartz and Moss, 
1992  ;   Fitzsimons et al., 2001a, 2001b  ). Notably, in car-
diac muscle both C1m and NEM-S1 activate force in the 
absence of Ca 
2+   (pCa 9.0), induce a leftward shift in the 
tension  –  pCa relationship, and accelerate   k    tr   at submaxi-
mal [Ca 
2+  ] (  Fitzsimons et al., 2001b  ). Both C1m and 
NEM-S1 also inhibit maximal Ca 
2+  -activated force at 
pCa 4.5. Because the latter effect of NEM-S1 is attrib-
uted to competitive inhibition of endogenous (cycling) 
cross-bridges by high concentrations of NEM-S1 (  Swartz 
and Moss, 1992  ), the similarities may suggest that C1m 
similarly limits S1 binding. However, although C1C2 
has been shown to bind to actin ( Razumova et al., 2006 ), 
competitive binding of C1m with myosin S1 has not yet 
been established. 
  A second possibility is that instead of binding to the 
thin fi  lament, C1m interacts with the thick fi  lament and 
promotes strong cross-bridge formation. According to 
this scenario, C1m might enhance formation of strongly 
bound cross-bridges and thereby indirectly activate the 
thin fi  lament. Consistent with this idea, there is evi-
dence that MyBP-C stabilizes a strongly bound post-
power stroke state (  Palmer et al., 2004  ). Furthermore, 
interactions with the thick fi  lament are plausible because 
C1C2 binds to myosin S2 (  Gruen and Gautel, 1999  ). 
  TABLE II  
  Summary Data of Effects of Recombinant N-terminal Proteins on Ca 
2+  -independent and -dependent Force 
Protein (  n  ) Concentration 
  (    M)
Total force 
  (pCa 4.5) 
    P/P  0   
Ca 
2+  -independent force 
  (pCa 9.0) 
    P/P  0   
Ca 
2+  -dependent force 
    P/P  0   
Control (13)   — 1.0    ±   0.0 0.11   ±   0.01 0.88   ±   0.01
C0C2 (5) 30 0.80   ±   0.06   
a   0.44    ±   0.03   
a   0.36    ±   0.06   
a   
C1C2 (4) 30 0.60   ±   0.10   
a   0.43    ±   0.06   
a   0.21    ±   0.12   
a   
C0C1m (5) 30 0.79   ±   0.07 0.42   ±   0.10   
a   0.30    ±   0.12   
a   
C1m (3) 30 0.88   ±   0.11 0.57   ±   0.29 0.31   ±   0.17   
a   
mC2 (4) 30 0.95   ±   0.08 0.09   ±   0.02 0.85   ±   0.06
C0C1 (3) 30 1.00   ±   0.03 0.07   ±   0.01 0.93   ±   0.04
C1C2(-m) (3) 30 1.07   ±   0.09 0.14   ±   0.01 0.94   ±   0.08
C3mC4 (3) 30 0.91   ±   0.05 0.08   ±   0.02 0.83   ±   0.04
   
a    Signifi  cance, P   <   0.05 versus control.584   Functional Effects of the MyBP-C Motif 
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despite opposite perturbations (protein knockout vs. 
protein addition) suggests that cMyBP-C may affect acto-
myosin interaction kinetics through multiple, distinct 
mechanisms. For instance, cMyBP-C has been proposed 
to tether myosin heads to the thick fi  lament (  Calaghan 
et al., 2000  ). Release of cross-bridge heads by disrupting 
the tether, either by knockout of cMyBP-C or phosphory-
lation of the motif, may thereby increase the spatial 
extent of myosin heads and hence accelerate interactions 
with actin (  Colson et al., 2008  ). On the other hand,   
Nagayama et al. (2007)   found evidence for both phos-
phorylation-dependent and -independent effects of 
cMyBP-C on cardiac contraction and relaxation and 
suggested that binding interactions with sarcomeric 
proteins other than S2 may be important for effects of 
cMyBP-C. In this regard, we and others have shown that the 
N terminus of cMyBP-C interacts with actin (  Kulikovskaya 
et al., 2003  ;   Razumova et al., 2006  ). It will therefore be of 
interest to determine whether interactions with actin, 
perhaps via the C1 and m-domains, mediate functional 
effects of cMyBP-C. 
  In summary, we have shown that the combination of 
C1 and the unique m-domain of cMyBP-C function to-
gether to increase Ca 
2+   sensitivity of tension, increase   k    tr   
at submaximal [Ca 
2+  ], and activate tension in the ab-
sence of Ca 
2+   (pCa 9.0). These results suggest that these 
two domains together constitute a functional subunit of 
cMyBP-C that promotes thin fi  lament activation. Future 
studies will be aimed at identifying the binding partner(s) 
for C1 and the MyBP-C motif and determining the mech-
anisms by which they affect actomyosin interactions. 
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